Details for 2021716969
Up to date per 25.04.2026
Actions
Details for 2021716969
Granted/Registered
European Patent
08.02.2023 A
22.04.2026 B1
23.03.2020
US
202062993443 P
11.06.2020
US
202063037783 P
05.08.2020
US
202063061497 P
21.08.2020
US
202063068593 P
30.10.2020
AU
2020260519
30.10.2020
CA
3097453
30.10.2020
JP
2020182046
30.10.2020
US
202017084957
C07K 16/24 20060101AFI20211001BHEP
Owner
MedImmune LimitedMilstein Building Granta Park Cambridge Cambridgeshire CB21 6GHGB
Representative
No representatives present
Inventor
COLICE, GeneAstraZeneca 1 MedImmune Way Gaithersburg, Maryland 20878US
VAN DER MERWE, Rene35 Church Street Thriplow Cambridgeshire SG8 7REGB
BAVEREL, Paul44 Marque House 143 Hills Road Cambridge Cambridgeshire CB2 8RAGB
Information about Fees